Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction
Jiaqi Li, Huang Siqing, Qin Wang, et al.
Phytomedicine (2022) Vol. 109, pp. 154601-154601
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Application of natural products in regulating ferroptosis in human diseases
Liyan Deng, Wen Tian, Lianxiang Luo
Phytomedicine (2024) Vol. 128, pp. 155384-155384
Closed Access | Times Cited: 6
Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy
Afsana Sheikh, Prashant Kesharwani, Waleed Hassan Almalki, et al.
Nano-Micro Letters (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases
Mengjiao Xu, Di Zhang, Jun Yan
Phytomedicine (2024) Vol. 130, pp. 155738-155738
Open Access | Times Cited: 6
Innovative anticancer molecule andrographolide: a concise review of its pharmacological targets
Venu Sharma, Gourav Kumar, Parveen Kumar, et al.
Natural Product Research (2025), pp. 1-13
Closed Access
CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
Xi Yan, Yinghao Niu, Yaojie Wang, et al.
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis
Xiaoyan Zhang, Guanghong Li, Hanbin Chen, et al.
Free Radical Biology and Medicine (2024) Vol. 218, pp. 190-204
Closed Access | Times Cited: 3
Knockdown of KBTBD7 attenuates septic lung injury by inhibiting ferroptosis and improving mitochondrial dysfunction
Xiang Li, Lin Zhao, ShiYu Xu, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112129-112129
Closed Access | Times Cited: 3
The therapeutic potential of andrographolide in cancer treatment
Jiaxuan Hu, Yi Li, Xin Xie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117438-117438
Open Access | Times Cited: 3
Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment
Jiahao Zhu, Peipei Shen, Yu Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies
Yunbin Li, Xiaosong Li, Jian Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Preparation of Biomimetic Selenium–Baicalein Nanoparticles and Their Targeted Therapeutic Application in Nonsmall Cell Lung Cancer
Huan Shi, Biaobiao Wang, Huilin Ma, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4476-4489
Closed Access | Times Cited: 2
The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
Bingru Liu, Yu Lu, Ayijiang Taledaohan, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 75-75
Open Access | Times Cited: 6
Network-based analysis identifies potential therapeutic ingredients of Chinese medicines and their mechanisms toward lung cancer
Mingrui Li, Gui-Yang Zhang, Qiang Tang, et al.
Computers in Biology and Medicine (2024) Vol. 173, pp. 108292-108292
Closed Access | Times Cited: 1
[Role of Ferroptosis in Non-small Cell Lung Cancer and Progress 
of Traditional Chinese Medicine Intervention].
Xiaoqi Guo, Tianqi Wang, Jinchan Xia, et al.
PubMed (2024) Vol. 27, Iss. 3, pp. 216-230
Closed Access | Times Cited: 1
A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer
Yueyang Zhang, Ying Chen, Bo Wang, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107459-107459
Closed Access | Times Cited: 1
Targeting ferroptosis regulators in lung cancer: Exploring natural products
Yuhao Wang, Cheng Shenghua, Chen Jueying, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e33934-e33934
Open Access | Times Cited: 1
Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway
Xiaoling Zhang, Wei Cai, Yiguang Yan
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 18, pp. 1371-1381
Closed Access | Times Cited: 1
TRIM11 promotes cell proliferation of non‐small cell lung cancer through the inhibition of ferroptosis by AMPK
Zheng Liang, Jian Li, Guoliang Zhang, et al.
The Clinical Respiratory Journal (2023) Vol. 17, Iss. 10, pp. 1006-1016
Open Access | Times Cited: 4
Andrographolide Induces ROS-Mediated Cytotoxicity, Lipid Peroxidation, and Compromised Cell Integrity in Saccharomyces cerevisiae
Tanaporn Phetruen, Bloem van Dam, Sittinan Chanarat
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1765-1765
Open Access | Times Cited: 2
Downregulation of HIGD1B induces mitochondria‐mediated apoptosis in gastric cancer cells by inactivating Akt and ERK pathways
Xiangyu Chen, Binghua Sun, Shuai Li
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access
A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells
Jun Liu, Kang Yang, Linlan Zhou, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112794-112794
Closed Access
Ferroptosis in the adjuvant treatment of lung cancer-the potential of selected botanical drugs and isolated metabolites
Xiaoyan Tian, Kunling Fu, Xuemin Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Targeting signaling pathways with andrographolide in cancer therapy (Review)
Nur Shahirah Shaharudin, Gurmeet Kaur Surindar Singh, Lay Kek Teh, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 5
Open Access
Non-pathogenic Trojan horse Nissle1917 triggers mitophagy through PINK1/Parkin pathway to discourage colon cancer
Yang Wang, Yao Liu, Xiaomin Su, et al.
Materials Today Bio (2024) Vol. 29, pp. 101273-101273
Open Access
Page 1 - Next Page

Scroll to top